Ligand Pharmaceuticals (LGND)
(Delayed Data from NSDQ)
$99.66 USD
-3.14 (-3.05%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $99.50 -0.16 (-0.16%) 7:30 PM ET
NA Value
NA Growth NA Momentum NA VGMKey Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $1.18 | 0.00% |
Earnings Summary
For their last quarter, Ligand Pharmaceuticals (LGND) reported earnings of $1.40 per share, beating the Zacks Consensus Estimate of $1.10 per share. This reflects a positive earnings surprise of 27.27%. Look out for LGND's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of $1.18 per share, reflecting a year-over-year increase of 15.69%.
Earnings History
Price & Consensus
Zacks News for LGND
Gilead (GILD) Up as Twice-Yearly HIV Shot Prevents Infection
LGND: What are Zacks experts saying now?
Zacks Private Portfolio Services